Physician profile
Robert George Davis
NPI 1831490051
$794.29
in general payments reported to CMS, 2019-2025
16 companies · $212 in 2025
The $212 reported for 2025 was more than what 82% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $34.64 · 2021: $131 · 2022: $263 · 2023: $45.72 · 2024: $107 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $171.34 | 2020-2025 | Skyrizi, Rinvoq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $147.46 | 2020-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $137.86 | 2021-2025 | Entyvio, Eohilia |
| Janssen Biotech, INC. | $41.63 | 2022 | |
| Madrigal Pharmaceuticals | $41.34 | 2025 | Rezdiffra |
| Phathom Pharmaceuticals, INC. | $38.97 | 2024-2025 | Voquezna |
| Gilead Sciences, INC. | $32.53 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $26.63 | 2024 | Dupixent |
| Braintree Laboratories, INC. | $25.04 | 2022 | |
| Ethicon US, LLC | $23.26 | 2022 | |
| Lilly USA, LLC | $22.45 | 2025 | Omvoh |
| Ardelyx, INC. | $21.94 | 2025 | Ibsrela |
| Merck Sharp & Dohme LLC | $18.97 | 2022 | |
| Qol Medical, LLC | $16.93 | 2022 | |
| Endo Pharmaceuticals INC. | $14.27 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $13.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.